Exhibit 10.2
JOINT COOPERATION AGREEMENT
BETWEEN:
Institute of Materia Medica
Chinese Acadamy of Medical Sciences
Peking Union Medical College
1 Xian Nong Tan ▇▇▇▇▇▇
▇▇▇▇▇▇▇, ▇▇▇▇▇ ......... (Hereinafter referred to as "IMM")
AND:
Sino Pharmaceuticals Corporation
▇▇▇▇ ▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇,
▇▇▇▇▇▇▇▇▇, ▇.▇. ▇▇▇ ▇▇▇
▇▇▇▇▇▇ ......... (Hereinafter referred to as "Sino")
WHEREAS IMM is an research organization, specializing in all aspects of new drug
research, development, commercialization and manufacturing, including all
aspects of clinical research and,
WHEREAS Sino is an established pharmaceuticals and nutraceuticals company
involved in the sales, marketing and distribution of pharmaceuticals and bulk
and formulated nutraceuticals in North America and Europe, and,
WHEREAS IMM and Sino are interested in working together and establishing a joint
cooperative in both parties interested area to develop, license, and market
IMM's existing drugs for the North American and European markets.
THEREFORE, in consideration of the above the aforementioned parties hereby enter
into this Agreement and hereby agree as follows:
1. That IMM and Sino shall jointly cooperate to market and sell several of
IMM's existing drugs, in the North American and European markets, under
specific licensing Agreements.
2. That IMM and Sino shall jointly cooperate in certain projects or both side
interested area, including research, develop and commercialize new drugs
and nutraceuticals for the North American and European markets.
3. That IMM might cooperate to contract manufacture and provide outsourcing
manufacturing facilities, at its Beijing Union Pharmaceuticals Factory,
certain specified drugs for Sino, for the North American and European
markets.
4. That any and all specific work or projects initiate, as part of or under
this Joint Cooperative Agreement, shall be conducted on a pre-arranged,
actually agreed, fee or cost basis between IMM and Sino.
5. This Agreement should not be exported to any other third parties.
6. The validity of this Agreement shall be for a period of five years from the
date of signing thereof.
THE PARTIES to this Agreement hereby lend their signatures this 21 day of
November 2002.
For, and on behalf of, ......... .........For, and on behalf of,
INSTITUTE OF MATERIA MEDICA.........SINO PHARMACEUTICALS CORP.
By:/s/______________________ ....... By:/s/__________________
Wang Xinolaing ......... .........▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇
......... ......... President & CEO